DrugPlus international is published 4 times a year* and reaches over 17,000 targetted subscribers in the fast moving drug discovery segment and provides essential information about the latest technological advances to Pharma and Biopharma's R&D t

DrugPlus international is published 4 times a year* and
reaches over 17,000 targetted subscribers in the fast moving
drug discovery segment and provides essential information
about the latest technological advances to Pharma and
Biopharma's R&D teams. DrugPlus international covers the drug discovery market,
reporting on new findings from science and industry that
underline and illustrate the advantages of new technologies.